Articles published by Travere Therapeutics, Inc.
Travere Therapeutics to Participate at Upcoming Investor Conferences
February 24, 2025
Travere Therapeutics to Submit sNDA for FILSPARI® (sparsentan) in FSGS
February 11, 2025
Travere Therapeutics Provides Corporate Update and 2025 Outlook
January 13, 2025
Travere Therapeutics to Present at Upcoming Investor Conferences
November 25, 2024
Travere Therapeutics Announces Proposed Public Offering of Common Stock
November 07, 2024
Travere Therapeutics to Present at Upcoming Investor Conferences
November 04, 2024
Travere Therapeutics Reports Third Quarter 2024 Financial Results
October 31, 2024
Travere Therapeutics to Report Third Quarter 2024 Financial Results
October 21, 2024
Travere Therapeutics to Present at Upcoming Investor Conferences
August 06, 2024
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.